Approval of conventional medicines in Cameroon in 2023: Why do some fail?

Full Length Research Paper

Zoa Bindzi Joseph Bertin Alexis
Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Ebolowa, Sangmélima 599, Cameroon.
Search for this author on:
Google Scholar

Etoundi Ada Valérie
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Minyem Ngombi Afuh Aude Perine
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Tsafack Edmond Elisée
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Khou-kouz Nkoulou Claude Hervé
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Mballa Magalie Flore
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Nyangono Ndongo Martin
Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Ebolowa, Sangmélima 599, Cameroon.
Search for this author on:
Google Scholar

Yaba Dana Basil
Department of Pharmacy, Drugs and Laboratories, Ministry of Public Health, Yaoundé, Cameroon.
Search for this author on:
Google Scholar

Nnanga Nga
Department of Galenics and Pharmaceutical Legislation, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé 3316, Cameroon.
Search for this author on:
Google Scholar

References

CSP (2022). Article L5111-1: Definition du Medicament, Legifrance. View

de Mazières C, Paris V (2004). La régulation de l'industrie pharmaceutique. Revue D'économie Financière pp. 241-265. Crossref

Feroyard A (2014). Constitution d'un dossier d'autorisation de mise sur le marche d'un médicament à usage humain et ses différentes procédures d'enregistrement en Europe. View

Geest S (2017). Van der, Les médicaments sur un marché camerounais, Crossref

Lexchin J (2008). Homologation progressive des médicaments?: promesse ou cacophonie?? Healthc. Policy 3:15-20. Crossref

MINSANTE (2013). Décret N°98-405/PM dU 22 Oct 1998 Fixant les Modalités d'Homologation et de Mise sur le Marché des Produits Pharmaceutiques, DPML. View

MINSANTE (2018). Guide Pratique de Soumission des Dossiers d'Homologation des Produits Pharmaceutiques, DPML.

MINSANTE (1998). Décret N°98-405/PM dU 22 Oct 1998 Fixant les Modalités d'Homologation et de Mise sur le Marché des Produits Pharmaceutiques, DPML. View

Pierre-Antoine D (2020). Importance des etudes de stabilite dans le domaine pharmaceutique: qualite, reglementation et processus general, Universite de Lyon. View

UEAC (2018). Les annexes au Règlement N° 05/13-UEAC-OCEAC-CM-SE-2 portant Référentiel d'Harmonisation des Procédures d'Homologation des Médicaments à usage Humain en Afrique Centrale, OCEAC. View

World Health Assembly (2002). Ensuring accessibility of essential medicines. WHO-Iris 55:2. View